The current place and indications of 131I-metaiodobenzylguanidine therapy in the era of peptide receptor radionuclide therapy: determinants to consider for evolving the best practice and envisioning a personalized approach

Nucl Med Commun. 2015 Jan;36(1):1-7. doi: 10.1097/MNM.0000000000000209.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • 3-Iodobenzylguanidine / metabolism
  • 3-Iodobenzylguanidine / therapeutic use*
  • Humans
  • Neoplasms / radiotherapy
  • Precision Medicine / methods*
  • Radiotherapy / methods*
  • Receptors, Peptide / metabolism*

Substances

  • Receptors, Peptide
  • 3-Iodobenzylguanidine